296 related articles for article (PubMed ID: 18572866)
1. [Type V phosphodiesterase inhibitor erection-provoking test with audio-visual sexual stimulation for the diagnosis of erectile dysfunction].
Zhu XW; Guo JP; Zhang FB; Zhong DC; Fang JJ; Li FY
Zhonghua Nan Ke Xue; 2008 May; 14(5):445-7. PubMed ID: 18572866
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
Ali ST
Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
[TBL] [Abstract][Full Text] [Related]
3. Is penile length a factor in treatment of erectile dysfunction with PDE-5 inhibitor?
Savas M; Yeni E; Ciftci H; Topal U; Utangac M; Verit A
J Androl; 2009; 30(5):515-9. PubMed ID: 19234311
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of sildenafil for Japanese patients with audio-visual sexual stimulation (AVSS) test by the RigiScan Plus.
Soh J; Naya Y; Ushijima S; Naitoh Y; Ochiai A; Mizutani Y; Kawauchi A; Miki T; Fujiwara T
Arch Androl; 2006; 52(3):163-8. PubMed ID: 16574596
[TBL] [Abstract][Full Text] [Related]
5. Clinically meaningful improvement on the quality of erection questionnaire in men with erectile dysfunction.
Hvidsten K; Carlsson M; Stecher VJ; Symonds T; Levinson I
Int J Impot Res; 2010; 22(1):45-50. PubMed ID: 19798060
[TBL] [Abstract][Full Text] [Related]
6. [Erectile dysfunction and obstructive sleep apnea syndrome].
Zhuravlev VN; Frank MA; Gomzhin AI
Urologiia; 2008; (2):35, 37-9. PubMed ID: 18572768
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the International Index of Erectile Function erectile domain scores and nocturnal penile tumescence and rigidity measurements: does one predict the other?
Yang CC; Porter MP; Penson DF
BJU Int; 2006 Jul; 98(1):105-9; discussion 109. PubMed ID: 16831153
[TBL] [Abstract][Full Text] [Related]
8. Using a three-dimension head mounted displayer in audio-visual sexual stimulation aids in differential diagnosis of psychogenic from organic erectile dysfunction.
Moon KH; Song PH; Park TC
Int J Impot Res; 2005; 17(6):519-22. PubMed ID: 15988547
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunction.
Francis SH; Corbin JD
Urol Clin North Am; 2005 Nov; 32(4):419-29, vi. PubMed ID: 16291034
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic efficacy of a course administration of vardenafil--inhibitor of phosphodiesterase-5--in erectile dysfunction].
Aliaev IuG; Vinarov AZ; Akhvlediani ND
Urologiia; 2007; (1):45-6, 49. PubMed ID: 17471999
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, tolerability and satisfaction with sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction.
Buvat J; Hatzichristou D; Maggi M; Farmer I; Martínez-Jabaloyas JM; Miller PJ; Schnetzler G
BJU Int; 2008 Dec; 102(11):1645-50. PubMed ID: 18710446
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and expectations of patients with erectile dysfunction: results of the SCORED study.
Claes H; Opsomer RJ; Andrianne R; Vanbelle S; Albert A; Vanderdonck F
Int J Impot Res; 2008; 20(4):418-24. PubMed ID: 18418390
[TBL] [Abstract][Full Text] [Related]
13. [Phosphodiesterase 5 inhibition in erectile dysfunction. Long-term administration without therapeutic advantage].
MMW Fortschr Med; 2009 Jan; 151(1-2):50-1. PubMed ID: 19227645
[No Abstract] [Full Text] [Related]
14. [Experience of using three phosphodiesterase type 5 inhibitors in the same period for the treatment of erectile dysfunction].
Zhang SX; Gao P
Zhonghua Nan Ke Xue; 2007 Mar; 13(3):226-8. PubMed ID: 17393785
[TBL] [Abstract][Full Text] [Related]
15. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil.
Bannowsky A; Schulze H; van der Horst C; Hautmann S; Jünemann KP
BJU Int; 2008 May; 101(10):1279-83. PubMed ID: 18284406
[TBL] [Abstract][Full Text] [Related]
16. Aging and sexual response in the laboratory in patients with erectile dysfunction.
Rowland DL; Incrocci L; Slob AK
J Sex Marital Ther; 2005; 31(5):399-407. PubMed ID: 16169823
[TBL] [Abstract][Full Text] [Related]
17. The use of vibrotactile stimulation for determining sexual potency in the laboratory in men with erectile problems: methodological considerations.
Rowland DL; den Ouden AH; Slob AK
Int J Impot Res; 1994 Sep; 6(3):153-61. PubMed ID: 7735360
[TBL] [Abstract][Full Text] [Related]
18. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
Bratus D; Hlebic G; Hajdinjak T
Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
[TBL] [Abstract][Full Text] [Related]
19. Visual erotic stimulation test for initial screening of psychogenic erectile dysfunction: a reliable noninvasive alternative?
Martins FE; Reis JP
J Urol; 1997 Jan; 157(1):134-9. PubMed ID: 8976235
[TBL] [Abstract][Full Text] [Related]
20. Psychogenic Erection Monitoring using the sexual stimulation score in 150 patients with impotence.
Kawanishi Y; Imagawa A; Hiraishi K; Kurokawa K
Hinyokika Kiyo; 1987 Nov; 33(11):1823-6. PubMed ID: 3445865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
